The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2024

Filed:

Jul. 18, 2019
Applicant:

Chemotherapeutisches Forschungsinstitut Georg-speyer-haus, Frankfurt am Main, DE;

Inventors:

Daniela S. Krause, Frankfurt am Main, DE;

Divij Verma, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/51 (2006.01); A61K 35/28 (2015.01); A61K 38/00 (2006.01); C12N 5/0789 (2010.01);
U.S. Cl.
CPC ...
C07K 14/51 (2013.01); A61K 35/28 (2013.01); C12N 5/0647 (2013.01); A61K 38/00 (2013.01); C12N 2501/155 (2013.01);
Abstract

The present invention pertains to periostin compounds for use in the prevention and treatment of haematological complications, such as adverse events from therapy or haematological diseases. In context of the present invention a therapeutic was developed for enhancing haematopoiesis in patients and to support haematopoietic stem cell (HSC) transplantation (HSCT) by administration of periostin compounds to patients or stem cell donors, or by contacting HSC directly with periostin compounds, for example ex vivo, to improve a transplant HSC preparation. The present invention provides periostin derived compounds such as polypeptides, peptides, nucleic acids, and other periostin-derived agents, that are used both in therapeutic applications and for improving haematopoiesis, for example in stem cell donor subjects or to treat HSC in vitro.


Find Patent Forward Citations

Loading…